Research ArticleResearch Article

Optimization of Autoclave Cycles and Selection of Formulation for Parenteral Products, Part III: Effect of Formulation Variables on Sporicidal Kinetics

Y. J. Wang, G. D. Leesman, M. E. Lipstein, H. I. Basch and D. C. Monkhouse
PDA Journal of Pharmaceutical Science and Technology March 1984, 38 (2) 78-82;

Article Information

vol. 38 no. 2 78-82
PubMed 
6726544
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received October 26, 1983
  • Accepted January 20, 1984
  • Published online March 1, 1984.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Y. J. Wang∆,
  2. G. D. Leesman,
  3. M. E. Lipstein,
  4. H. I. Basch and
  5. D. C. Monkhouse
  1. E. R. Squibb & Sons, Inc., New Brunswick, New Jersey
  1. ∆ Author to whom inquiries should be directed. Present Address: Ortho Pharmaceutical Corp., Rt 202, Raritan, N.J.

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
Optimization of Autoclave Cycles and Selection of Formulation for Parenteral Products, Part III: Effect of Formulation Variables on Sporicidal Kinetics
Y. J. Wang, G. D. Leesman, M. E. Lipstein, H. I. Basch, D. C. Monkhouse
PDA Journal of Pharmaceutical Science and Technology Mar 1984, 38 (2) 78-82;
Twitter logo Facebook logo Mendeley logo

Jump to section